The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
A nodoame is a small tablet intended to be dissolved slowly in the mouth to temporarily soothe irritated tissues of the throat (usually due to a sore throa).
The global Nodoame market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Nodoame is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nodoame is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Nodoame include Comvita, Vocalzone, Good Health, Kanro, UHA Mikakuto Co.,Ltd, RYUKAKUSAN Co.,Ltd., Zirkulin, Ricola and Fisherman's Friend, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nodoame, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nodoame.
Report Scope
The Nodoame market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nodoame market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nodoame manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Comvita
Vocalzone
Good Health
Kanro
UHA Mikakuto Co.,Ltd
RYUKAKUSAN Co.,Ltd.
Zirkulin
Ricola
Fisherman's Friend
Golden Throat Holdings Group Company Limited
Nin Jiom
Wong Lo Kat
Poon Goor Soe
Guilin Sanjin Pharmaceutical Company Limited
Segment by Type
Medicinal
Food
Segment by Application
Supermarket
Drugstore
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nodoame manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nodoame in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A nodoame is a small tablet intended to be dissolved slowly in the mouth to temporarily soothe irritated tissues of the throat (usually due to a sore throa).
The global Nodoame market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Nodoame is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Nodoame is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Nodoame include Comvita, Vocalzone, Good Health, Kanro, UHA Mikakuto Co.,Ltd, RYUKAKUSAN Co.,Ltd., Zirkulin, Ricola and Fisherman's Friend, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Nodoame, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nodoame.
Report Scope
The Nodoame market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Nodoame market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nodoame manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Comvita
Vocalzone
Good Health
Kanro
UHA Mikakuto Co.,Ltd
RYUKAKUSAN Co.,Ltd.
Zirkulin
Ricola
Fisherman's Friend
Golden Throat Holdings Group Company Limited
Nin Jiom
Wong Lo Kat
Poon Goor Soe
Guilin Sanjin Pharmaceutical Company Limited
Segment by Type
Medicinal
Food
Segment by Application
Supermarket
Drugstore
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nodoame manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nodoame in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Nodoame Market Overview
1.1 Product Overview and Scope of Nodoame
1.2 Nodoame Segment by Type
1.2.1 Global Nodoame Market Value Comparison by Type (2024-2030)
1.2.2 Medicinal
1.2.3 Food
1.3 Nodoame Segment by Application
1.3.1 Global Nodoame Market Value by Application: (2024-2030)
1.3.2 Supermarket
1.3.3 Drugstore
1.4 Global Nodoame Market Size Estimates and Forecasts
1.4.1 Global Nodoame Revenue 2019-2030
1.4.2 Global Nodoame Sales 2019-2030
1.4.3 Global Nodoame Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Nodoame Market Competition by Manufacturers
2.1 Global Nodoame Sales Market Share by Manufacturers (2019-2024)
2.2 Global Nodoame Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Nodoame Average Price by Manufacturers (2019-2024)
2.4 Global Nodoame Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Nodoame, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nodoame, Product Type & Application
2.7 Nodoame Market Competitive Situation and Trends
2.7.1 Nodoame Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nodoame Players Market Share by Revenue
2.7.3 Global Nodoame Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nodoame Retrospective Market Scenario by Region
3.1 Global Nodoame Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Nodoame Global Nodoame Sales by Region: 2019-2030
3.2.1 Global Nodoame Sales by Region: 2019-2024
3.2.2 Global Nodoame Sales by Region: 2025-2030
3.3 Global Nodoame Global Nodoame Revenue by Region: 2019-2030
3.3.1 Global Nodoame Revenue by Region: 2019-2024
3.3.2 Global Nodoame Revenue by Region: 2025-2030
3.4 North America Nodoame Market Facts & Figures by Country
3.4.1 North America Nodoame Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Nodoame Sales by Country (2019-2030)
3.4.3 North America Nodoame Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nodoame Market Facts & Figures by Country
3.5.1 Europe Nodoame Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Nodoame Sales by Country (2019-2030)
3.5.3 Europe Nodoame Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nodoame Market Facts & Figures by Country
3.6.1 Asia Pacific Nodoame Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Nodoame Sales by Country (2019-2030)
3.6.3 Asia Pacific Nodoame Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nodoame Market Facts & Figures by Country
3.7.1 Latin America Nodoame Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Nodoame Sales by Country (2019-2030)
3.7.3 Latin America Nodoame Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nodoame Market Facts & Figures by Country
3.8.1 Middle East and Africa Nodoame Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Nodoame Sales by Country (2019-2030)
3.8.3 Middle East and Africa Nodoame Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Nodoame Sales by Type (2019-2030)
4.1.1 Global Nodoame Sales by Type (2019-2024)
4.1.2 Global Nodoame Sales by Type (2025-2030)
4.1.3 Global Nodoame Sales Market Share by Type (2019-2030)
4.2 Global Nodoame Revenue by Type (2019-2030)
4.2.1 Global Nodoame Revenue by Type (2019-2024)
4.2.2 Global Nodoame Revenue by Type (2025-2030)
4.2.3 Global Nodoame Revenue Market Share by Type (2019-2030)
4.3 Global Nodoame Price by Type (2019-2030)
5 Segment by Application
5.1 Global Nodoame Sales by Application (2019-2030)
5.1.1 Global Nodoame Sales by Application (2019-2024)
5.1.2 Global Nodoame Sales by Application (2025-2030)
5.1.3 Global Nodoame Sales Market Share by Application (2019-2030)
5.2 Global Nodoame Revenue by Application (2019-2030)
5.2.1 Global Nodoame Revenue by Application (2019-2024)
5.2.2 Global Nodoame Revenue by Application (2025-2030)
5.2.3 Global Nodoame Revenue Market Share by Application (2019-2030)
5.3 Global Nodoame Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Comvita
6.1.1 Comvita Corporation Information
6.1.2 Comvita Description and Business Overview
6.1.3 Comvita Nodoame Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Comvita Nodoame Product Portfolio
6.1.5 Comvita Recent Developments/Updates
6.2 Vocalzone
6.2.1 Vocalzone Corporation Information
6.2.2 Vocalzone Description and Business Overview
6.2.3 Vocalzone Nodoame Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Vocalzone Nodoame Product Portfolio
6.2.5 Vocalzone Recent Developments/Updates
6.3 Good Health
6.3.1 Good Health Corporation Information
6.3.2 Good Health Description and Business Overview
6.3.3 Good Health Nodoame Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Good Health Nodoame Product Portfolio
6.3.5 Good Health Recent Developments/Updates
6.4 Kanro
6.4.1 Kanro Corporation Information
6.4.2 Kanro Description and Business Overview
6.4.3 Kanro Nodoame Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Kanro Nodoame Product Portfolio
6.4.5 Kanro Recent Developments/Updates
6.5 UHA Mikakuto Co.,Ltd
6.5.1 UHA Mikakuto Co.,Ltd Corporation Information
6.5.2 UHA Mikakuto Co.,Ltd Description and Business Overview
6.5.3 UHA Mikakuto Co.,Ltd Nodoame Sales, Revenue and Gross Margin (2019-2024)
6.5.4 UHA Mikakuto Co.,Ltd Nodoame Product Portfolio
6.5.5 UHA Mikakuto Co.,Ltd Recent Developments/Updates
6.6 RYUKAKUSAN Co.,Ltd.
6.6.1 RYUKAKUSAN Co.,Ltd. Corporation Information
6.6.2 RYUKAKUSAN Co.,Ltd. Description and Business Overview
6.6.3 RYUKAKUSAN Co.,Ltd. Nodoame Sales, Revenue and Gross Margin (2019-2024)
6.6.4 RYUKAKUSAN Co.,Ltd. Nodoame Product Portfolio
6.6.5 RYUKAKUSAN Co.,Ltd. Recent Developments/Updates
6.7 Zirkulin
6.6.1 Zirkulin Corporation Information
6.6.2 Zirkulin Description and Business Overview
6.6.3 Zirkulin Nodoame Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zirkulin Nodoame Product Portfolio
6.7.5 Zirkulin Recent Developments/Updates
6.8 Ricola
6.8.1 Ricola Corporation Information
6.8.2 Ricola Description and Business Overview
6.8.3 Ricola Nodoame Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ricola Nodoame Product Portfolio
6.8.5 Ricola Recent Developments/Updates
6.9 Fisherman's Friend
6.9.1 Fisherman's Friend Corporation Information
6.9.2 Fisherman's Friend Description and Business Overview
6.9.3 Fisherman's Friend Nodoame Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Fisherman's Friend Nodoame Product Portfolio
6.9.5 Fisherman's Friend Recent Developments/Updates
6.10 Golden Throat Holdings Group Company Limited
6.10.1 Golden Throat Holdings Group Company Limited Corporation Information
6.10.2 Golden Throat Holdings Group Company Limited Description and Business Overview
6.10.3 Golden Throat Holdings Group Company Limited Nodoame Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Golden Throat Holdings Group Company Limited Nodoame Product Portfolio
6.10.5 Golden Throat Holdings Group Company Limited Recent Developments/Updates
6.11 Nin Jiom
6.11.1 Nin Jiom Corporation Information
6.11.2 Nin Jiom Nodoame Description and Business Overview
6.11.3 Nin Jiom Nodoame Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Nin Jiom Nodoame Product Portfolio
6.11.5 Nin Jiom Recent Developments/Updates
6.12 Wong Lo Kat
6.12.1 Wong Lo Kat Corporation Information
6.12.2 Wong Lo Kat Nodoame Description and Business Overview
6.12.3 Wong Lo Kat Nodoame Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Wong Lo Kat Nodoame Product Portfolio
6.12.5 Wong Lo Kat Recent Developments/Updates
6.13 Poon Goor Soe
6.13.1 Poon Goor Soe Corporation Information
6.13.2 Poon Goor Soe Nodoame Description and Business Overview
6.13.3 Poon Goor Soe Nodoame Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Poon Goor Soe Nodoame Product Portfolio
6.13.5 Poon Goor Soe Recent Developments/Updates
6.14 Guilin Sanjin Pharmaceutical Company Limited
6.14.1 Guilin Sanjin Pharmaceutical Company Limited Corporation Information
6.14.2 Guilin Sanjin Pharmaceutical Company Limited Nodoame Description and Business Overview
6.14.3 Guilin Sanjin Pharmaceutical Company Limited Nodoame Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Guilin Sanjin Pharmaceutical Company Limited Nodoame Product Portfolio
6.14.5 Guilin Sanjin Pharmaceutical Company Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nodoame Industry Chain Analysis
7.2 Nodoame Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nodoame Production Mode & Process
7.4 Nodoame Sales and Marketing
7.4.1 Nodoame Sales Channels
7.4.2 Nodoame Distributors
7.5 Nodoame Customers
8 Nodoame Market Dynamics
8.1 Nodoame Industry Trends
8.2 Nodoame Market Drivers
8.3 Nodoame Market Challenges
8.4 Nodoame Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Food & Beverages Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
